Use of Daridorexant among Patients with Chronic Insomnia: A Retrospective Observational Analysis
Insomnia is the most prevalent sleep disorder, affecting millions worldwide and taking a heavy toll on patient health with significant social and economic impact. Even though there are multiple different types of insomnia medications and behavioral therapies, there are still many individuals for who...
Main Authors: | Scott G. Williams, Domingo Rodriguez-Cué |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-05-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/12/9/3240 |
Similar Items
-
A Comprehensive Review of Daridorexant, a Dual-Orexin Receptor Antagonist as New Approach for the Treatment of Insomnia
by: Wojciech Ziemichód, et al.
Published: (2022-09-01) -
Safety of Dual Orexin Receptor Antagonist Daridorexant: A Disproportionality Analysis of Publicly Available FAERS Data
by: Giuseppe Cicala, et al.
Published: (2024-03-01) -
Different doses of dual orexin receptor antagonists in primary insomnia: a Bayesian network analysis
by: Tao Xue, et al.
Published: (2023-05-01) -
Alliance for Sleep Clinical Practice Guideline on Switching or Deprescribing Hypnotic Medications for Insomnia
by: Nathaniel F. Watson, et al.
Published: (2023-03-01) -
The effects of different dosages of dual orexin receptor antagonists and zolpidem on sleep and cognitive function: A meta-analysis and systematic review
by: Mengzhen Zhou, et al.
Published: (2023-12-01)